Thermal Biofeedback for the Treatment of Diabetic Neuropathy

Status Completed

Clinical Trial Summary

The purpose of this study is to examine potential treatment options for a condition in diabetics that causes tingling, pain, and numbness in the hands and /or feet, also known as diabetic peripheral neuropathy.

Clinical Trial Description

Participants attend 6 sessions lasting from 35 minutes to 2 hours (depending on the session). Sessions can be scheduled once or twice per week. Sessions involve a walking task, filling out questionnaires, and having temperature of hands and feet monitored. This study involves no drugs, blood draws, or any other invasive procedures. Participants are urged to continue the treatment of diabetes and diabetic neuropathy as directed by their physician for the duration of their involvement with the study. After 3 months, a packet of questionnaires will be mailed with a stamped addressed envelope to be returned. ;

Study Design

Related Conditions & MeSH terms

Diabetic Neuropathies
Diabetic Neuropathy, Painful
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT00858351
Study type	Interventional
Source	Northwestern University
Contact
Status	Completed
Phase	N/A
Start date	November 2007
Completion date	April 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04988321` - Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms	N/A
Completed	`NCT00385671` - An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain	Phase 4
Completed	`NCT00159679` - Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy	Phase 4
Completed	`NCT00141401` - Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.	Phase 3
Active, not recruiting	`NCT04469270` - Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00553475` - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00381719` - Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT00058968` - A Study for the Treatment of Painful Diabetic Neuropathy	Phase 3
Completed	`NCT05029297` - Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.	Phase 3
Completed	`NCT02215252` - A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)	Phase 2
Completed	`NCT00785577` - A Study for Treatment of Pain in Patients With Diabetic Neuropathy.	Phase 2
Completed	`NCT03047278` - Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.	Phase 4
Completed	`NCT01628627` - Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy	Phase 4
Completed	`NCT03315598` - Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain	N/A
Completed	`NCT01057693` - Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT01564459` - Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)	Phase 2
Recruiting	`NCT01214590` - Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01089556` - A Study in Painful Diabetic Neuropathy	Phase 3
Completed	`NCT00501202` - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).	Phase 2